Compare CENX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENX | MIR |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Aluminum | Industrial Machinery/Components |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.6B |
| IPO Year | 2004 | N/A |
| Metric | CENX | MIR |
|---|---|---|
| Price | $48.85 | $18.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $57.00 | $27.63 |
| AVG Volume (30 Days) | 2.2M | ★ 3.3M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | ★ $1,893,200,000.00 | N/A |
| Revenue This Year | $11.48 | $24.05 |
| Revenue Next Year | $12.88 | $7.40 |
| P/E Ratio | ★ $117.90 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.05 | $12.00 |
| 52 Week High | $59.12 | $30.28 |
| Indicator | CENX | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 33.73 |
| Support Level | $48.08 | N/A |
| Resistance Level | $51.08 | $22.23 |
| Average True Range (ATR) | 3.52 | 1.04 |
| MACD | -0.83 | -0.13 |
| Stochastic Oscillator | 4.17 | 0.00 |
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.